Mean platelet volume: A controversial marker of disease activity in Crohn's disease

European Journal of Medical Research

Volumn 17, Issue 1, 2012, Pages

  Liu, Song ^a,b   Ren, Jianan ^a   Han, Gang ^c   Wang, Gefei ^a   Gu, Guosheng ^a   Xia, Qiuyuan ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c JILIN UNIVERSITY   (China)

Author keywords

C reactive protein; Crohn's disease; Erythrocyte sedimentation rate; Inflammatory bowel disease; Mean platelet volume

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; THROMBOCYTE VOLUME; ADULT; BODY MASS; CASE CONTROL STUDY; CELL DIFFERENTIATION; INFLAMMATION; METABOLISM; PATHOLOGY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE; THROMBOCYTE COUNT;

ADULT; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD SEDIMENTATION; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; PLATELET COUNT; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84870895690     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-17-27     Document Type: Article

References (49)

1. Unravelling the pathogenesis of inflammatory bowel disease. Xavier RJ, Podolsky DK, Nature 2007 448 427 434 10.1038/nature06005 17653185
2. Review article: inflammatory bowel disease and genetics. Weersma RK, van Dullemen HM, van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G, Aliment Pharmacol Ther 2007 26 Suppl 2 57 65 18081650
3. Laboratory evaluation of inflammatory bowel disease. Wong A, Bass D, Curr Opin Pediatr 2008 20 566 570 10.1097/MOP.0b013e32830d3aaf 18781120
4. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Sandborn WJ, Loftus EV Jr, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR, Inflamm Bowel Dis 2001 7 192 201 10.1097/00054725-200108000-00003 11515844
5. Blood platelets and inflammation: their relationship with liver and digestive diseases. Ripoche J, Clin Res Hepatol Gastroenterol 2011 35 353 357 10.1016/j.clinre.2011.02.012 21482218
6. Thrombin generation in pediatric patients with Crohn's disease. Bernhard H, Deutschmann A, Leschnik B, Schweintzger S, Novak M, Hauer A, Muntean W, Inflamm Bowel Dis 2011 17 2333 2339 10.1002/ibd.21631 21287673
7. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Danese S, Motte C, Cde L, Fiocchi C, Am J Gastroenterol 2004 99 938 945 10.1111/j.1572-0241.2004.04129.x 15128364
8. Platelet dysfunction: a new dimension in inflammatory bowel disease. Collins CE, Rampton DS, Gut 1995 36 5 8 10.1136/gut.36.1.5 7890235
9. Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease. Shah A, Morgan G, Rose JD, Fifield R, Rhodes J, Med Lab Sci 1989 46 79 80 2779388
10. Platelet density and size in inflammatory bowel disease. Jaremo P, Sandberg-Gertzen H, Thromb Haemost 1996 75 560 561 8743178
11. Usefulness of laboratory data in estimation of Crohn's disease activity. Zubcevic N, Mesihovic R, Zubcevic S, Med Arh 2010 64 33 36 20422823
12. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA, Am J Gastroenterol 2001 96 776 781 10.1111/j.1572-0241.2001.03621.x 11280550
13. Mean platelet volume: a link between thrombosis and inflammation? Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD, Curr Pharm Des 2011 17 47 58 10.2174/138161211795049804 21247392
14. Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters. Diaz-Ricart M, Brunso L, Pino M, Navalon F, Jou JM, Heras M, White JG, Escolar G, Thromb Res 2010 126 30 e35 10.1016/j.thromres.2010.04.002 20427079
15. Mean platelet volume measurement, EDTA or citrate? Dastjerdi MS, Emami T, Najafian A, Amini M, Hematology 2006 11 317 319 10.1080/10245330600954163 17607580
16. Recent understanding of IBD pathogenesis: implications for future therapies. Kucharzik T, Maaser C, Lugering A, Kagnoff M, Mayer L, Targan S, Domschke W, Inflamm Bowel Dis 2006 12 1068 1083 10.1097/01.mib.0000235827.21778. d5 17075348
17. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ, Am J Gastroenterol 2008 103 162 169 10.1111/j.1572-0241.2007.01556.x 17916108
18. Current and future diagnostic approaches: from serologies to imaging. Bruining DH, Loftus EV, Curr Gastroenterol Rep 2007 9 489 496 10.1007/s11894-007-0065-5 18377802
19. Laboratory markers in IBD: useful, magic, or unnecessary toys? Vermeire S, Van Assche G, Rutgeerts P, Gut 2006 55 426 431 10.1136/gut.2005.069476 16474109
20. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Shine B, Berghouse L, Jones JE, Landon J, Clin Chim Acta 1985 148 105 109 10.1016/0009-8981(85)90219-0 3995779
21. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Poullis AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A, Mendall MA, Eur J Gastroenterol Hepatol 2002 14 409 412 10.1097/00042737-200204000-00013 11943955
22. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Khan K, Schwarzenberg SJ, Sharp H, Greenwood D, Weisdorf-Schindele S, Inflamm Bowel Dis 2002 8 325 329 10.1097/00054725- 200209000-00003 12479647
23. Review of fecal biomarkers in inflammatory bowel disease. Sutherland AD, Gearry RB, Frizelle FA, Dis Colon Rectum 2008 51 1283 1291 10.1007/s10350-008- 9310-8 18543035
24. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, Carlson M, Scand J Clin Lab Invest 2007 67 810 820 10.1080/00365510701452838 18034391
25. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD, Rheumatol Int 2010 30 1125 1129 10.1007/s00296-009-1345-1 20066426
26. The mean platelet volume in patients with essential and white coat hypertension. Coban E, Yazicioglu G, Berkant Avci A, Akcit F, Platelets 2005 16 435 438 10.1080/09537100500163572 16236605
27. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Tavil Y, Sen N, Yazici H, Turfan M, Hizal F, Cengel A, Abaci A, Platelets 2010 21 368 372 10.3109/09537101003628421 20521863
28. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Schafer A, Bauersachs J, Curr Vasc Pharmacol 2008 6 52 60 10.2174/157016108783331295 18220940
29. The mean platelet volume in patients with obesity. Coban E, Ozdogan M, Yazicioglu G, Akcit F, Int J Clin Pract 2005 59 981 982 10.1111/j.1742-1241. 2005.00500.x 16033624
30. Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa). Polinska B, Matowicka-Karna J, Kemona H, Folia Histochem Cytobiol 2011 49 119 124 21526498
31. Platelets as immune mediators: their role in host defense responses and sepsis. Li Z, Yang F, Dunn S, Gross AK, Smyth SS, Thromb Res 2011 127 184 188 10.1016/j.thromres.2010.10.010 21075430
32. Relationship among circulating leukocytes, platelets, and microvascular responses during induction of chronic colitis. Harris NR, Carter PR, Watts MN, Zhang S, Kosloski-Davidson M, Grisham MB, Pathophysiology 2011 18 305 311 10.1016/j.pathophys.2011.05.003 21680162
33. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Mannaioni PF, Di Bello MG, Masini E, Inflamm Res 1997 46 4 18 10.1007/PL00000158 9117517
34. Mean platelet volume may be reflects the disease activity of ulcerative colitis. Gülü M, Sakall H, Yakar T, Eur J Gen Med 2010 7 259 263
35. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Yuksel O, Helvaci K, Basar O, Koklu S, Caner S, Helvaci N, Abayli E, Altiparmak E, Platelets 2009 20 277 281 10.1080/09537100902856781 19459134
36. Mean platelet volume (MPV) in Crohn's disease patients. Douda T, Bures J, Rejchrt S, Kopacova M, Pecka M, Maly J, Cas Lek Cesk 2006 145 870 873 17168422
37. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS, J Thromb Haemost 2010 8 148 156 10.1111/j.1538-7836.2009.03584.x 19691485
38. Platelet size in stroke patients. O'Malley T, Langhorne P, Elton RA, Stewart C, Stroke 1995 26 995 999 10.1161/01.STR.26.6.995 7762052
39. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W, Stroke 2004 35 1688 1691 10.1161/01.STR.0000130512.81212.a2 15143290
40. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB, J Thromb Haemost 2010 8 157 162 10.1111/j.1538-7836. 2009.03498.x 19496920
41. Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H, Blood Coag Fibrinol 2008 19 411 414 10.1097/MBC.0b013e3283049697
42. Increased mean platelet volume in rheumatic mitral stenosis: a possible factor for thromboembolic events. Yavuz B, Ertugrul DT, Yalcin AA, Kucukazman M, Ata N, Dal K, J Cardiol 2009 53 204 207 10.1016/j.jjcc.2008.10.012 19304123
43. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M, Am J Gastroenterol 2007 102 174 186 10.1111/j.1572-0241.2006.00943.x 17100967
44. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE, Lancet 1989 2 1057 1062 2572794
45. Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Collins CE, Rampton DS, Aliment Pharmacol Ther 1997 11 237 247 10.1046/j.1365-2036.1997.153328000.x 9146760
46. Factor XIIIA subunit and Crohn's disease. Hudson M, Wakefield AJ, Hutton RA, Sankey EA, Dhillon AP, More L, Sim R, Pounder RE, Gut 1993 34 75 79 10.1136/gut.34.1.75 8094363
47. Platelets circulate in an activated state in inflammatory bowel disease. Collins CE, Cahill MR, Newland AC, Rampton DS, Gastroenterology 1994 106 840 845 8143990
48. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ, Gut 1991 32 1531 1534 10.1136/gut.32.12.1531 1773961
49. Thromboembolism in inflammatory bowel disease: role of platelets. Webberley MJ, Hart MT, Melikian V, Gut 1993 34 247 251 10.1136/gut.34.2.247 8432482